My First Million · Podcast summary
3 killer businesses hiding in plain sight
Sam and Shaan discuss how to find business ideas in unexpected places, from monkey testing to obscure manufacturing, and how to cultivate a mindset of noticing opportunities.
Listen on the show ↗Key takeaways
- 🐒Over 20% of all drugs are tested on monkeys, with companies like Charles River Labs generating billions in revenue from this specialized service.00:44
- 💰The cost of a single monkey for testing can be as high as $50,000, a significant increase from $2,000 before the COVID-19 pandemic.06:04
- 🇨🇳China's sudden halt on monkey exports created a massive supply shock, leading other countries like Cambodia and Vietnam to step in.06:20
- 👁️The "art of noticing" involves paying close attention to seemingly mundane details, as every product or service has an entrepreneur behind it.09:34
- 💡Paul Graham's formula for great work suggests following your excitement and interest to find less competitive fields and uncover unmet needs.20:57
- 🤩Enthusiasm is an underrated trait that can be a powerful motivator for tackling difficult tasks, despite often being perceived as "low-status" by smart people.25:17
Chapters
- 0:00Introduction to Hidden Businesses
- 0:40The Wild World of Monkey Testing
- 15:25The Art of Noticing
- 34:03Paul Graham's Formula for Great Work
- 41:54The Power of Enthusiasm and Childhood Passions
- 50:55Embrace Your Quirks and Let Your Freak Flag Fly
- 1:03:51The Emotion of Awe in San Francisco
- 1:12:20The Art Thief and Unfiltered Passions
The digest
Sam and Shaan dive into the fascinating world of niche businesses, revealing that opportunities are often hidden in plain sight, waiting for those with a keen eye and a willingness to explore unconventional paths. They share insights on how to cultivate a mindset of noticing, drawing lessons from comedians, artists, and even personal childhood experiences.
The Wild World of Monkey Testing
Shaan kicks off the discussion with a surprising revelation about the pharmaceutical industry: the extensive use of monkeys in drug testing. He explains that over 20% of all drugs are tested on monkeys, specifically species like the long-tailed cynomolgus, chosen for their intelligence and genetic proximity to humans. This isn't a small operation; companies like Charles River Labs, a publicly traded entity with $4 billion in annual revenue, specialize in providing research and testing services to biotech companies. They even bought a monkey breeding business for $500 million to secure their supply chain. The cost of these monkeys skyrocketed during COVID-19, from $2,000 to $20,000, and even up to $50,000 per monkey, due to increased demand and China's sudden halt on exports. This led to other countries like Cambodia and Vietnam stepping in to fill the supply gap. Shaan recounts a wild story of a Cambodian wildlife director being arrested in the US for allegedly passing off wild monkeys as lab-bred, highlighting the murky ethical and logistical complexities of this hidden industry.
Keep reading in The Digest
The full 4-minute article, 4 more sections, and every new episode from My First Million and the creators you follow.
- The Art of Noticing: Uncovering Hidden Businesses
- Paul Graham's Formula for Great Work
- The Power of Enthusiasm and Childhood Passions
- Don't Be Ashamed: Embrace Your Quirks
More from My First Million
We tested Instinct, MUSE and Grokbot. They’re ridiculous.
Sean and Sam explore the explosive growth and fierce competition among new AI personal assistants like Instinct, Muse, and Grokbot, revealing how these tools are democratizing luxury-level help and reshaping daily life and work.
MIT scientist: Elon Musk was right, we are almost certainly in a simulation
MIT computer scientist Riz Stanford explores why Elon Musk and others believe we are almost certainly living in a simulation, connecting AI, quantum physics, and ancient mysticism.
There’s 98 days until 2027...Do this and you’ll thank yourself on Jan 1st
Sam Parr and Sean discuss maximizing the final 99 days of the year, creativity systems, business insights from media dynasty Advance Publishing, and personal resilience.
Whatnot founder: This is the future of e-commerce
Whatnot founder Grant LaFontaine shares the story of building a $20 billion live shopping marketplace, from its humble beginnings selling Funko Pops to becoming a major player in e-commerce.
Coach for SpaceX & OpenAI destroys your limiting beliefs for 88 minutes straight
Joe Hudson, a coach for leaders at SpaceX and OpenAI, discusses how to identify and destroy limiting beliefs, improve self-talk, and approach life with an experimental mindset.
David Rubenstein: We took $5M and turned it into $500B
David Rubenstein, co-founder of The Carlyle Group, shares his journey from a blue-collar Baltimore upbringing to building a global private equity powerhouse, offering insights into entrepreneurship, leadership, and the pursuit of success.